Texas Capital Bank Wealth Management Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$670K Sell
23,846
-2,278
-9% -$60.6K 0.04% 181
2025
Q4
$650K Buy
26,124
+13,463
+106% +$340K 0.04% 179
2025
Q3
$323K Buy
+12,661
New +$312K 0.03% 195
2024
Q4
Sell
-31,662
Closed -$916K 195
2024
Q3
$916K Sell
31,662
-23,208
-42% -$677K 0.09% 78
2024
Q2
$1.54M Sell
54,870
-30,415
-36% -$837K 0.16% 61
2024
Q1
$2.37M Sell
85,285
-59,295
-41% -$1.65M 0.26% 50
2023
Q4
$2.74M Buy
144,580
+79,668
+123% +$2.41M 0.32% 45
2023
Q3
$2.15M Buy
64,912
+1,033
+2% +$36.5K 0.27% 55
2023
Q2
$2.34M Buy
63,879
+17,071
+36% +$664K 0.25% 59
2023
Q1
$1.91M Buy
46,808
+31,114
+198% +$1.34M 0.22% 61
2022
Q4
$804K Buy
15,694
+437
+3% +$21K 0.1% 93
2022
Q3
$668K Sell
15,257
-1,094
-7% -$53.2K 0.09% 89
2022
Q2
$857K Sell
16,351
-256
-2% -$13K 0.1% 80
2022
Q1
$860K Buy
16,607
+603
+4% +$31.3K 0.08% 82
2021
Q4
$945K Sell
16,004
-956
-6% -$47.4K 0.08% 82
2021
Q3
$729K Sell
16,960
-157
-0.9% -$6.96K 0.07% 81
2021
Q2
$670K Buy
17,117
+875
+5% +$34K 0.08% 86
2021
Q1
$588K Sell
16,242
-35,052
-68% -$1.24M 0.08% 85
2020
Q4
$1.89M Sell
51,294
-81,353
-61% -$2.98M 0.28% 60
2020
Q3
$4.62M Buy
132,647
+43,935
+50% +$1.54M 0.75% 26
2020
Q2
$2.75M Buy
88,712
+16,789
+23% +$570K 0.62% 31
2020
Q1
$2.23M Buy
71,923
+9,637
+15% +$328K 0.64% 26
2019
Q4
$2.31M Buy
+62,286
New +$2.22M 0.51% 37

Other funds holding PFE

Texas Capital Bank Wealth Management Services's PFE Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services reduced its Pfizer (PFE) stake by 8.7% in Q1 2026, selling an estimated $60.6K and leaving 23,846 shares worth $670K. The position accounts for 0.04% of the portfolio, ranked #181.

Texas Capital Bank Wealth Management Services first reported a position in PFE in Q4 2019 and has held it in 23 quarters since. The position peaked at $4.62M in Q3 2020. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 23,846 shares of Pfizer worth $670K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services sold 2,278 Pfizer shares in Q1 2026, an estimated $60.6K.
  • Pfizer made up 0.04% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #181 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Pfizer in Q4 2019 and has held it in 23 quarters since.
  • Texas Capital Bank Wealth Management Services's Pfizer position peaked at $4.62M in Q3 2020.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.